AstraZeneca PLC

AstraZeneca And Daiichi Sankyo Withdraw EU Marketing Application For Datopotamab Deruxtecan

23 ديسمبر 2024 23:40:25 بحسب NASDAQ US Markets

Is AstraZeneca Stock a Buy?

22 ديسمبر 2024 03:16:51 بحسب NASDAQ US Markets

3 Unstoppable Stocks to Buy Right Now

15 ديسمبر 2024 03:33:05 بحسب NASDAQ US Markets

March 2025 Options Now Available For AstraZeneca (AZN)

06 ديسمبر 2024 08:01:12 بحسب NASDAQ US Markets

AZN : TROPION Analysis Reveals Datopotamab Deruxtecan Efficacy In Advanced EGFR-Mutated Lung Cancer

05 ديسمبر 2024 19:31:29 بحسب NASDAQ US Markets

FDA Approves AstraZeneca's Imfinzi For Limited-Stage Small Cell Lung Cancer

04 ديسمبر 2024 18:59:20 بحسب NASDAQ US Markets

AstraZeneca Names A MSK Leader To Global Cancer Post

25 نوفمبر 2024 08:17:34 بحسب Forbes - World

Lunit Collaborates With AstraZeneca To Develop AI-powered Digital Pathology Solutions

18 نوفمبر 2024 10:17:39 بحسب NASDAQ US Markets

Is AstraZeneca a Buy as It Eyes the Weight Loss Market?

14 نوفمبر 2024 04:43:11 بحسب NASDAQ US Markets

AstraZeneca Plc (AZN) Q3 2024 Earnings Call Transcript

12 نوفمبر 2024 14:04:51 بحسب NASDAQ US Markets

AstraZeneca To Invest $3.5 Bln In US To Expand R&D And Manufacturing

12 نوفمبر 2024 00:02:49 بحسب NASDAQ US Markets

AstraZeneca Q3 Net Income Rises; Upgrades 2024 Guidance

12 نوفمبر 2024 00:02:49 بحسب NASDAQ US Markets

AstraZeneca : Wainzua Recommended By CHMP For EU Approval In Hereditary Transthyretin Amyloidosis

21 أكتوبر 2024 00:00:49 بحسب NASDAQ US Markets

AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline

08 أكتوبر 2024 11:20:34 بحسب NASDAQ Stocks

Arcus Announces Clinical Trial Collaboration With AstraZeneca To Evaluate Casdatifan

02 أكتوبر 2024 14:15:33 بحسب NASDAQ US Markets

AstraZeneca Becomes Oversold (AZN)

24 سبتمبر 2024 15:47:41 بحسب NASDAQ US Markets

AstraZeneca Becomes Oversold (AZN)

24 سبتمبر 2024 15:45:01 بحسب NASDAQ Stocks

CHMP Endorses AstraZeneca's Fasenra in Rare Autoimmune Disease

24 سبتمبر 2024 10:14:18 بحسب NASDAQ Stocks

AstraZeneca: TROPION-Breast01 Phase III Trial Fails To Achieve Statistical Significance

23 سبتمبر 2024 00:29:23 بحسب NASDAQ US Markets

AZN : IMFINZI Regimen Reduces Death Risk By 25% In Late-Stage Muscle-Invasive Bladder Cancer Trial

15 سبتمبر 2024 10:57:59 بحسب NASDAQ US Markets